Telemedicine had an impact on carbon emissions equivalent to reducing up to 130,000 car trips each month in 2023

The findings suggest it could have a positive effect on climate change

5:00 AM

person looking at ipad with provider on screen smiling
UCLA/Proxima Studio-stock.adobe.com

This story was written by Enrique Rivero and originally published by the UCLA public relations office

Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of up to 130,000 gas operated vehicles, suggesting it could have a positive effect on climate change, UCLA and Michigan led research finds.

The findings, published in the peer-reviewed American Journal of Managed Care, suggest that telemedicine could have a modest but noticeable impact on the environment by decreasing the number of vehicles traveling to and from medical appointments.

They could also have policy implications, says co-senior author John N. Mafi, M.D., associate professor-in-residence of medicine in the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA.

“As Congress debates whether to extend or modify pandemic-era telehealth flexibilities, our results provide important evidence for policymakers to consider, namely that telemedicine has the potential to reduce the carbon footprint of US health care delivery,” Mafi said.

The United States health system now contributes about 9%, and transportation comprises about 29%, of greenhouse emissions in the country, the researchers write in the paper.

The researchers used de-identified data from the Milliman MedInsight Emerging Experience database to quantify nearly 1.5 million telemedicine visits, including about 66,000 in rural areas, during the April 1 through June 30, 2023 study period.

They estimate that between 741,000 and 1.35 million of those were substitutes for in-person visits. 

Extrapolating from these calculations, the researchers estimate that CO2 emissions were reduced by between 21.4 million and 47.6 million kg each month in the U.S. due to telemedicine use, which translates to the amount produced by 61,000 to 130,000 gas powered vehicles or recycling 1.8 million to 4 million trash bags.

"The health care sector contributes significantly to the global carbon footprint,” said A. Mark Fendrick, M.D., professor of medicine and director of Center for Value-Based Insurance Design at the University of Michigan and the study’s co-senior author. 

“Our findings suggest that the environmental impact of medical care delivery can be reduced when lower carbon options, such as telemedicine, are substituted for other services that produce more emissions."

The researchers note some limitations to their findings. 

Their sampling method was based on data that was from a single, easy to access source rather than a random selection, so the findings may not represent the broader population or account for regional variations. 

Also, driving distances and vehicle market share were based on data sources from before 2023, though driving distances to in-person care were not likely to differ much from what they were prior to that year. 

Finally, telemedicine use has fallen since the end of the COVID pandemic, which may have led the researchers to overestimate the amount of emissions averted due to variations in telemedicine use rates.

Additional authors: Benjo Delarmente, Artem Romanov, Manying Cui, Chi-Hong Tseng, and Catherine Sarkisian of UCLA; Melody Craff, Dale Skinner, and Michael Hadfield of Milliman MedInsight, and Cheryl Damberg of RAND.

Funding: The study was funded by the National Institutes of Health/National Institute on Aging.


More Articles About:

telehealth telemedicine All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

A M. Fendrick

A Mark Fendrick, MD

Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

surgeon and surgical team set up in OR with teal gear on and masks
Health Lab

C.S. Mott Children’s Hospital first in country to implant expandable heart valve during FDA review phase

University of Michigan Health C.S. Mott Children’s Hospital is the first hospital in the country to implant an Edwards Lifesciences- produced Autus Valve during the FDA review phase of the breakthrough synthetic pulmonary valve.
liver with yellow circles over it
Health Lab

Evolving causes, diagnosis of drug-induced liver injury

The causes of drug-induced liver injury have evolved over the last 20 years, according to a review in Hepatology Communications.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has extended public comment on proposed temporary rescheduling of 7-OH and has rescheduled three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.
woman itching skin orange blue button down
Health Lab

A first-of-its-kind treatment for mastocytosis

A new drug called Avapritinib achieved longterm safety approval for indolent systemic mastocytosis.
kid at table not wanting to eat breakfast with parent blurred in background white coloring milk on table
Health Lab

Many parents face challenges getting kids to eat a healthy breakfast before school

Three-quarters of parents report at least one barrier to their child starting the day with a healthy meal on a typical school day, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
Microscope images of prostate cancer cells
Health Lab

New drug combination may help treat advanced prostate cancer

University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors may slow the growth of treatment-resistant prostate cancer by targeting transdifferentiated tumors.